72 related articles for article (PubMed ID: 2652600)
21. Antirejection treatment in kidney transplantation--is there a proved rationale for the general use of monoclonal antibodies?
Reis HJ; Hopt UT; Greger B; Schareck WD; Bockhorn H
Transplant Proc; 1987 Oct; 19(5):3565-9. PubMed ID: 2823424
[No Abstract] [Full Text] [Related]
22. Transplantation 1992: the year in review.
Goodman ER; Hardy MA
Clin Transpl; 1992; ():285-97. PubMed ID: 1306706
[No Abstract] [Full Text] [Related]
23. [Immunologic aspects of kidney transplantation].
Frei D; Irlé C; Jeannet M
Ther Umsch; 1986 Feb; 43(2):133-7. PubMed ID: 3515607
[No Abstract] [Full Text] [Related]
24. Immunosuppression in cardiac transplantation.
Rose EA; Addonizio LJ
Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
[No Abstract] [Full Text] [Related]
25. Monitoring immunosuppression following renal transplantation.
Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
van Gelder T; Zietse R; Yzermans JN; Rischen-Vos J; Vaessen LM; Weimar W
Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
[No Abstract] [Full Text] [Related]
27. Treatment of steroid resistant acute rejection after renal transplantation.
Oh CK; Kim YS; Kim MS; Kim SI; Park K
Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737
[No Abstract] [Full Text] [Related]
28. Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantation.
Fassbinder W; Bechstein PB; Stutte HJ; Scheuermann EH; Hanke P; Knöner M; Dathe G; Jonas D; Schoeppe W
Neth J Med; 1985; 28(6):265-7. PubMed ID: 3892329
[No Abstract] [Full Text] [Related]
29. Serum immunosuppressive acidic protein as an immune parameter following renal transplantation.
Koyama I; Taguchi Y; Watanabe T; Nagashima N; Kadokura M; Omoto R
Transplant Proc; 1994 Aug; 26(4):2157-8. PubMed ID: 8066707
[No Abstract] [Full Text] [Related]
30. Renal transplantation efficacy is dependent on pretransplantation immunologic monitoring.
Drannik GN; Metodiev K; Nenov D; Baran EY
Transplant Proc; 1989 Feb; 21(1 Pt 2):1926-9. PubMed ID: 2652627
[No Abstract] [Full Text] [Related]
31. The use of OKT3 rescue therapy after orthotopic liver transplantation--the University of Nebraska Medical Center experience.
Wood RP; Shaw BW; Williams L
Transplant Proc; 1988 Feb; 20(1 Suppl 1):254-9. PubMed ID: 3279616
[No Abstract] [Full Text] [Related]
32. Treatment of antibody-mediated rejection after kidney transplantation.
Sureshkumar KK; Oti IU; Baroody SC; Hussain SM; Carpenter BJ; Nghiem DD; Marcus RJ
Transplant Proc; 2008 Jun; 40(5):1373-4. PubMed ID: 18589109
[No Abstract] [Full Text] [Related]
33. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
34. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
[No Abstract] [Full Text] [Related]
35. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
36. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
37. [Medical management before and after homologous transplantation of the kidney].
Xu QJ
Zhonghua Yi Xue Za Zhi; 1982 Oct; 62(10):591-4. PubMed ID: 6817883
[No Abstract] [Full Text] [Related]
38. Immunologic monitoring of monoclonal antibody therapy: comparison of five antibodies as immunosuppressants of renal allograft rejection.
Cosimi AB; Colvin RB; Jaffers GJ; Giorgi JV; Delmonico FL; Fuller TC; Russell PS
Transplant Proc; 1984 Dec; 16(6):1459-61. PubMed ID: 6390847
[No Abstract] [Full Text] [Related]
39. Primate model for the study of in vitro--in vivo immunologic monitoring correlates: studies of in vitro correlates of rejection in rhesus monkeys treated with clinical ATG.
Williams EA; Scott JD; Thomas FT; Thomas JM
Transplant Proc; 1978 Sep; 10(3):581-4. PubMed ID: 309672
[No Abstract] [Full Text] [Related]
40. Intensive care and immediate follow-up of children after renal transplantation.
Seikaly MG; Sanjad SA
Transplant Proc; 2001 Aug; 33(5):2821-4. PubMed ID: 11498173
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
